| VIS ID | Virus | Ensembl ID | Gene Type | Target Gene | Oncogene | Tumor Suppressor Gene | NCBI ID | Uniprot ID |
|---|---|---|---|---|---|---|---|---|
| TVIS44005531 | HTLV-1 | ENSG00000087245.13 | protein_coding | MMP2 | No | No | 4313 | P08253 |
| TVIS44036049 | HTLV-1 | ENSG00000087245.13 | protein_coding | MMP2 | No | No | 4313 | P08253 |
Target Gene Table
▼
TCGA Plot Options
▼
Drug Information
▼
| Gene | MMP2 |
|---|---|
| DrugBank ID | DB04866 |
| Drug Name | Halofuginone |
| Target ID | BE0000642 |
| UniProt ID | P08253 |
| Regulation Type | |
| PubMed IDs | 11099465 |
| Citations | Elkin M, Miao HQ, Nagler A, Aingorn E, Reich R, Hemo I, Dou HL, Pines M, Vlodavsky I: Halofuginone: a potent inhibitor of critical steps in angiogenesis progression. FASEB J. 2000 Dec;14(15):2477-85. |
| Groups | Investigational; Vet_approved |
| Direct Classification | Quinazolines |
| SMILES | [H][C@]1(O)CCCN[C@]1([H])CC(=O)CN1C=NC2=C(C=C(Cl)C(Br)=C2)C1=O |
| Pathways | |
| PharmGKB | |
| ChEMBL | CHEMBL1199540 |
